Works matching IS 13524585 AND DT 2023 AND VI 29 AND IP 10


Results: 22
    1
    2
    3
    4

    Immune-mediated colitis associated with ocrelizumab: A new safety risk.

    Published in:
    Multiple Sclerosis Journal, 2023, v. 29, n. 10, p. 1275, doi. 10.1177/13524585231195854
    By:
    • Kim, Tiffany;
    • Brinker, Allen;
    • Croteau, David;
    • Lee, Paul R;
    • Baldassari, Laura E;
    • Stevens, Jessica;
    • Hughes, Alice;
    • Tomaino, Juli;
    • deFonseka, Arushi;
    • Altepeter, Tara;
    • Kortepeter, Cindy M
    Publication type:
    Article
    5
    6
    7
    8

    Low transfer of cladribine into human milk.

    Published in:
    Multiple Sclerosis Journal, 2023, v. 29, n. 10, p. 1346, doi. 10.1177/13524585231183547
    By:
    • Datta, Palika;
    • Hale, Thomas W;
    • Thiel, Sandra;
    • Gold, Ralf;
    • Hellwig, Kerstin
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting.

    Published in:
    Multiple Sclerosis Journal, 2023, v. 29, n. 10, p. 1240, doi. 10.1177/13524585231187120
    By:
    • Carnero Contentti, Edgar;
    • Lopez, Pablo A;
    • Tkachuk, Verónica;
    • Vrech, Carlos;
    • Zarate, María A;
    • Correale, Jorge;
    • Deri, Norma;
    • Luetic, Geraldine;
    • Marrodan, Mariano;
    • Pagani Cassara, Fátima;
    • Tavolini, Darío;
    • Ysrraelit, María Célica;
    • Balbuena, María E;
    • Hryb, Javier;
    • Chiganer, Edson;
    • Leguizamon, Felisa;
    • Knorre, Eduardo;
    • Zanga, Gisela;
    • Pestchanker, Claudia;
    • Barboza, Andrés
    Publication type:
    Article
    20
    21
    22